Loading publications…
The last 5 uploaded publications
Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Ischemic Stroke due to Postmenopausal Hormone Therapy
Jacques E. Rossouw, Karen Johnson, Mary Pettinger, Mary Cushman, Per Morten Sandset, Lewis H. Kuller, Frits R. Rosendaal, Jan Rosing, Sylvia Wasserthal-Smoller, Lisa W. Martin, JoAnn E. Manson, Kamakshi Lakshminarayan, José G. Merino, J.A. Lynch (2012). Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Ischemic Stroke due to Postmenopausal Hormone Therapy. Stroke, 43(4), pp. 952-957, DOI: 10.1161/strokeaha.111.643072.
Article126 days agoTissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy
Karen Johnson, Aaron K. Aragaki, Rebecca D. Jackson, Alex P. Reiner, Per Morten Sandset, Jan Rosing, Anders Erik Astrup Dahm, Frits R. Rosendaal, JoAnn E. Manson, Lisa W. Martin, Simin Liu, Lewis H. Kuller, Mary Cushman, Jacques E. Rossouw (2015). Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy. Arteriosclerosis Thrombosis and Vascular Biology, 36(2), pp. 418-424, DOI: 10.1161/atvbaha.115.306905.
Article126 days ago